- Telo Genomics Corp. (TSXV: TELO, OTCQB: TDSGF) faces a $530,000 lawsuit from former President Sherif Louis over alleged unpaid notices and bonuses.
- The company plans to file a statement of defence and counterclaim to vigorously contest the claim.
- The outcome of the legal proceedings could have potential financial implications for Telo Genomics.
Telo Genomics Corp. (TSXV: TELO, OTCQB: TDSGF), headquartered in Toronto, has announced the receipt of a Statement of Claim from Sherif Louis, its former President. The claim demands approximately $530,000 for alleged unpaid notice and bonuses. Telo Genomics has stated its intention to contest this claim and will proceed with filing a statement of defence and a counterclaim.
This legal development underscores a dispute between Telo Genomics and its former executive, which could lead to significant financial liabilities, dependent on the court's decision. The company has assured stakeholders of its commitment to a rigorous defence strategy in light of these allegations.
Telo Genomics operates within the diagnostics and research industry in the healthcare sector, with its shares trading on TSXV under the ticker TELO and on OTCQB as TDSGF. The outcome of this lawsuit may have financial repercussions for the company, potentially impacting its market position and investor confidence.